Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, June 6, 2024

Distal Medium Vessel Occlusion Strokes: Understanding the Present and Paving the Way for a Better Future

 

But you tell us NOTHING ON 100% RECOVERY RESULTS!  The only goal in stroke, I guess that won't be important to you until you are the 1 in 4 per WHO that has a stroke Might be too late then for you to solve the 100% problem!

So no reporting or measurement of 100% recovery, obviously not important to the medical staff or researchers. But vastly important to stroke survivors. 

“What's measured, improves.” So said management legend and author Peter F. Drucker 

You'll want 100% recovery when you are the 1 in 4 per WHO that has a stroke! Explain how you're going to get to 100% recovery if you don't start that research RIGHT NOW!

Distal Medium Vessel Occlusion Strokes: Understanding the Present and Paving the Way for a Better Future

J Stroke. 2024;26(2):190-202
Publication date (electronic) : 2024 May 30
doi : https://doi.org/10.5853/jos.2023.02649
1UPMC Stroke Institute, Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
2Department of Neurology, Ajou University Medical Center, Ajou University School of Medicine, Suwon, Korea
3Department of Neurology, Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA, USA
4UPMC Stroke Institute, Department of Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
5Department of Neuroradiology, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal
Correspondence: Raul G. Nogueira University of Pittsburgh Medical Center Stroke Institute, 200 Lothrop Street, C-400 PUH, Pittsburgh, PA 15213, USA Tel: +1-412-647-8080 Email: raul.g.nogueira@icloud.com
Received 2023 August 12; Revised 2024 February 2; Accepted 2024 February 6.

Abstract

Distal medium vessel occlusions (DMVOs) are thought to cause as many as 25% to 40% of all acute ischemic strokes and may result in substantial disability amongst survivors. Although intravenous thrombolysis (IVT) is more effective for distal than proximal vessel occlusions, the overall efficacy of IVT remains limited in DMVO with less than 50% of patients achieving reperfusion and about 1/3 to 1/4 of the patients failing to achieve functional independence. Data regarding mechanical thrombectomy (MT) among these patients remains limited. The smaller, thinner, and more tortuous vessels involved in DMVO are presumably associated with higher procedural risks whereas a lower benefit might be expected given the smaller amount of tissue territory at risk. Recent advances in technology have shown promising results in endovascular treatment of DMVOs with room for future improvement. In this review, we discuss some of the key technical and clinical considerations in DMVO treatment including the anatomical and clinical terminology, diagnostic modalities, the role of IVT and MT, existing technology, and technical challenges as well as the contemporary evidence and future treatment directions.

No comments:

Post a Comment